Terveystalo suunnittelee listautumisantia ja listautumista Nasdaq Helsinkiin
September 14, 2017 01:48 ET
|
Terveystalo Oyj
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Ei julkistettavaksi tai...
The Nomination Committee’s proposal for the Board of Directors of Transcom WorldWide AB (publ) and the motivated opinion
April 20, 2015 11:30 ET
|
Transcom WorldWide S.A.
Background
In accordance with the resolution of the 2014 Annual General Meeting regarding
the procedure for the Nomination Committee, a Nomination Committee was convened
in October 2014 by Cristina...
Valberedningens förslag och motiverat yttrande angående styrelsen i Transcom WorldWide AB (publ)
April 20, 2015 11:30 ET
|
Transcom WorldWide S.A.
Bakgrund
I enlighet med beslut vid årsstämman 2014 sammankallades i oktober 2014 en
valberedning av Cristina Stenbeck (i egenskap av representant för den största
aktieägaren, Investment AB Kinnevik,...
BIOHIT GROUP INTERIM REPORT Q2/2014
August 21, 2014 02:30 ET
|
Biohit Oyj
Biohit Oyj Interim Report, 21 August 2014 at 9:30 am local time (EEST)
SUMMARY
January–June / H1 2014
Net sales grew by 50.9% compared with H1/2013
Net sales EUR 2.0 million (EUR 1.4...
Enrollment to clinical trials for prevention of migraine-type headache
May 20, 2014 07:15 ET
|
Biohit Oyj
Biohit Oyj Press Release May 20, 2014 at 2:15 pm local time (EEST)
Biohit Oyj initiates two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium®...
BIOHIT GROUP INTERIM REPORT Q1/2014
May 08, 2014 02:30 ET
|
Biohit Oyj
Biohit Oyj Stock Exchange Release, 8 May 2014 at 9:30 am local time (EEST)
SUMMARY
January–March 2014
Net sales grew by 67.5 % compared with Q1/2013
Net sales EUR 0.9 million (EUR 0.6...
Biohit Oyj starts two clinical trials with Acetium® capsule for prevention of migraine-type headache
April 29, 2014 09:30 ET
|
Biohit Oyj
Biohit Oyj Stock Exchange Release April 29, 2014 at 4:30 pm local time (EEST)
Biohit Oyj initiates two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of...
YIT:n toteuttama toimisto- ja liikekeskus Dixi harjakorkeudessa
April 03, 2014 07:00 ET
|
YIT
Vantaan Tikkurilaan rakentuvan toimisto- ja liikekeskus Dixin ensimmäinen vaihe on edennyt harjannostajaisvaiheeseen. Vuoden 2014 lopussa valmistuva ensimmäinen vaihe sisältää lähes 14 000 m2,...
Oriola-KD:n varsinaisessa yhtiökokouksessa 2014 valittavaa hallitusta koskeva yhtiön nimeämisvaliokunnan suositus
January 30, 2014 02:30 ET
|
Oriola-KD Oyj
Oriola-KD Oyj:n pörssitiedote 30.1.2014 klo 9.30
Oriola-KD:n varsinaisessa yhtiökokouksessa 2014 valittavaa hallitusta koskeva
yhtiön nimeämisvaliokunnan suositus
Oriola-KD Oyj:n...
Recommendation by the Nomination Committee of Oriola-KD Corporation concerning the Board of Directors to be elected by the 2014 Annual General Meeting
January 30, 2014 02:30 ET
|
Oriola-KD Oyj
Oriola-KD Corporation Stock Exchange Release 30 January 2014 at 9.30 a.m.
Recommendation by the Nomination Committee of Oriola-KD Corporation concerning
the Board of Directors to be elected by the...